173 related articles for article (PubMed ID: 37847430)
1. Clinical characteristics and therapeutic outcomes of acromegalic patients with giant growth hormone-secreting pituitary adenomas: a single-center study of 67 cases.
Chen M; Duan L; Miao H; Yu N; Yang S; Wang L; Gong F; Yao Y; Zhu H
Pituitary; 2023 Dec; 26(6):675-685. PubMed ID: 37847430
[TBL] [Abstract][Full Text] [Related]
2. Giant growth hormone-secreting pituitary adenomas from the endocrinologist's perspective.
Koylu B; Firlatan B; Sendur SN; Oguz SH; Dagdelen S; Erbas T
Endocrine; 2023 Mar; 79(3):545-553. PubMed ID: 36318446
[TBL] [Abstract][Full Text] [Related]
3. Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly.
Cardinal T; Rutkowski MJ; Micko A; Shiroishi M; Jason Liu CS; Wrobel B; Carmichael J; Zada G
Neurosurg Focus; 2020 Jun; 48(6):E10. PubMed ID: 32480366
[TBL] [Abstract][Full Text] [Related]
4. Presurgical treatment with somatostatin analogues in growth hormone-secreting pituitary adenomas: A long-term single-center experience.
Lv L; Hu Y; Zhou P; Zhang S; Yin S; Zhang N; Jiang S
Clin Neurol Neurosurg; 2018 Apr; 167():24-30. PubMed ID: 29433055
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[TBL] [Abstract][Full Text] [Related]
6. Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria.
Kreutzer J; Vance ML; Lopes MB; Laws ER
J Clin Endocrinol Metab; 2001 Sep; 86(9):4072-7. PubMed ID: 11549628
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Factors of Acromegalic Patients with Growth Hormone-Secreting Pituitary Adenoma After Transsphenoidal Surgery.
Taweesomboonyat C; Oearsakul T
World Neurosurg; 2021 Feb; 146():e1360-e1366. PubMed ID: 33309643
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and therapeutic outcomes of GH/TSH cosecreting pituitary adenomas: experience of a single pituitary center.
Yu N; Duan L; Hu F; Yang S; Liu J; Chen M; Yao Y; Deng K; Feng F; Lian X; Mao X; Zhu H
Front Endocrinol (Lausanne); 2023; 14():1197244. PubMed ID: 37324275
[TBL] [Abstract][Full Text] [Related]
9. Hyperprolactinemia and Hypopituitarism in Acromegaly and Effect of Pituitary Surgery: Long-Term Follow-up on 529 Patients.
Guo X; Zhang R; Zhang D; Wang Z; Gao L; Yao Y; Deng K; Bao X; Feng M; Xu Z; Yang Y; Lian W; Wang R; Ma W; Xing B
Front Endocrinol (Lausanne); 2021; 12():807054. PubMed ID: 35154007
[TBL] [Abstract][Full Text] [Related]
10. Acromegaly without imaging evidence of pituitary adenoma.
Lonser RR; Kindzelski BA; Mehta GU; Jane JA; Oldfield EH
J Clin Endocrinol Metab; 2010 Sep; 95(9):4192-6. PubMed ID: 20610592
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and complications of neurosurgical treatment of acromegaly.
Krzentowska-Korek A; Gołkowski F; Bałdys-Waligórska A; Hubalewska-Dydejczyk A
Pituitary; 2011 Jun; 14(2):157-62. PubMed ID: 21107739
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic endonasal transsphenoidal surgery for growth hormone-secreting pituitary adenomas.
Hofstetter CP; Mannaa RH; Mubita L; Anand VK; Kennedy JW; Dehdashti AR; Schwartz TH
Neurosurg Focus; 2010 Oct; 29(4):E6. PubMed ID: 20887131
[TBL] [Abstract][Full Text] [Related]
13. Management of aggressive growth hormone secreting pituitary adenomas.
Donoho DA; Bose N; Zada G; Carmichael JD
Pituitary; 2017 Feb; 20(1):169-178. PubMed ID: 27987061
[TBL] [Abstract][Full Text] [Related]
14. Acromegaly.
Scacchi M; Cavagnini F
Pituitary; 2006; 9(4):297-303. PubMed ID: 17077948
[TBL] [Abstract][Full Text] [Related]
15. Endoscopic therapy and curative effect in pituitary adenoma patients complicated by acromegalic cardiomyopathy.
Zhou H; Zha Z; Li X; Chen X; Wang J; Su Z
Neurosurg Rev; 2018 Jul; 41(3):869-875. PubMed ID: 29238923
[TBL] [Abstract][Full Text] [Related]
16. Effects of preoperative octreotide treatment on different subtypes of 90 GH-secreting pituitary adenomas and outcome in one surgical centre.
Abe T; Lüdecke DK
Eur J Endocrinol; 2001 Aug; 145(2):137-45. PubMed ID: 11454508
[TBL] [Abstract][Full Text] [Related]
17. Expression of the long non-coding RNA H19 and MALAT-1 in growth hormone-secreting pituitary adenomas and its relationship to tumor behavior.
Lu T; Yu C; Ni H; Liang W; Yan H; Jin W
Int J Dev Neurosci; 2018 Jun; 67():46-50. PubMed ID: 29604339
[TBL] [Abstract][Full Text] [Related]
18. Giant GH-secreting pituitary adenomas: management of rare and aggressive pituitary tumors.
Shimon I; Jallad RS; Fleseriu M; Yedinak CG; Greenman Y; Bronstein MD
Eur J Endocrinol; 2015 Jun; 172(6):707-13. PubMed ID: 25792375
[TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics and Postoperative Recovery of Hypopituitarism in Patients with Nonfunctional Pituitary Adenoma.
Zhang R; Wang Z; Gao L; Guo X; Feng C; Deng K; Lian W; Yao Y; Feng M; Bao X; Wang R; Xing B
World Neurosurg; 2019 Jun; 126():e1183-e1189. PubMed ID: 30880207
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone secreting pituitary adenomas show distinct extrasellar extension patterns compared to nonfunctional pituitary adenomas.
Pangal DJ; Wishart D; Shiroishi MS; Ruzevick J; Carmichael JD; Zada G
Pituitary; 2022 Jun; 25(3):480-485. PubMed ID: 35334028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]